SPIEGELMAN DANIEL K has filed 18 insider transactions across 5 companies since May 2023.
Most recent transaction: a disposition of 88 shares of SPRUCE BIOSCIENCES, INC. ($SPRB) on December 11, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | D | Stock Option (right to buy) | 88 | $0.00 | 0.0000 | 1,070,370 | 100.00% | 0.01% |
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | D | Stock Option (Right to Buy) | 400 | $0.00 | 0.0000 | 1,070,370 | 100.00% | 0.04% |
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | A | Stock Option (Right to Buy) | 400 | $0.00 | 400.0000 | 1,070,370 | 9999.99% | 0.04% |
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | A | Stock Option (Right to Buy) | 458 | $0.00 | 458.0000 | 1,070,370 | 9999.99% | 0.04% |
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | A | Stock Option (right to buy) | 88 | $0.00 | 88.0000 | 1,070,370 | 9999.99% | 0.01% |
| Dec. 11, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | D | Stock Option (Right to Buy) | 458 | $0.00 | 0.0000 | 1,070,370 | 100.00% | 0.04% |
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | SPIEGELMAN DANIEL K | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| July 22, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 42,231,285 | 9999.99% | 0.07% |
| June 10, 2025 | vTv Therapeutics Inc. | $VTVT | SPIEGELMAN DANIEL K | Director | A | Director stock option (right to buy) | 4000 | $16.59 | 10,000.0000 | 5,771,052 | 66.67% | 0.07% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | SPIEGELMAN DANIEL K | Not found | A | Common Stock | 16634 | $0.00 | 16,634.0000 | 43,214,918 | 9999.99% | 0.04% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | SPIEGELMAN DANIEL K | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| June 25, 2024 | vTv Therapeutics Inc. | $VTVT | SPIEGELMAN DANIEL K | Director | A | Director stock option (right to buy) | 6000 | $17.22 | 6,000.0000 | 2,084,973 | 9999.99% | 0.29% |
| June 4, 2024 | MYRIAD GENETICS INC | $MYGN | SPIEGELMAN DANIEL K | Director | S | Common Stock | 3788 | $22.05 | 32,917.0000 | 0 | 10.32% | 0.00% |
| June 3, 2024 | MYRIAD GENETICS INC | $MYGN | SPIEGELMAN DANIEL K | Director | S | Common Stock | 3788 | $22.04 | 36,705.0000 | 0 | 9.35% | 0.00% |
| May 22, 2024 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | MYRIAD GENETICS INC | $MYGN | SPIEGELMAN DANIEL K | Director | S | Common Stock | 8638 | $23.01 | 40,493.0000 | 0 | 17.58% | 0.00% |
| June 1, 2023 | MYRIAD GENETICS INC | $MYGN | SPIEGELMAN DANIEL K | Director | A | Common Stock | 15151 | $0.00 | 49,131.0000 | 0 | 44.59% | 0.00% |
| May 25, 2023 | SPRUCE BIOSCIENCES, INC. | $SPRB | SPIEGELMAN DANIEL K | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |